Medical news
of the North Caucasus
Scientific journal
Mass media registration certificate dated December 7, 2006.
Series ПИ #ФС 77-26521.
Federal service for surveillance over non-violation of the legislation in the sphere of mass communications and protection of cultural heritage.
ISSN 2073-8137

Site search

Correspondence address
310 Mira Street, Stavropol, Russia, 355017

+7 8652 352524; +7 8652 353229.

+7 8652 352524.


Angiotensin converting ensyme inhibitors (Captopril and Monopril) effect in children with dilated cardiomiopathy

[Original research] [Pediatrics]
Natalia Berezneva; Elena Arsenyeva; Elena Basargina; Vsevolod Pinelis; Nato Vashakmadze;

The aim was to assess the effect and safety of angiotensin converting enzyme inhibitors (ACEI) (captopril and monopril) in children with dilated cardiomyopathy (DCMP).

Material and methods. Serum concentrations of angiotensin converting enzyme was detected by ELISA in 20 children with DCMP before administration of ACE, 2 weeks after therapeutic dose obtaining and after preparation changing (captopril to monopril). Absence of adverse effects like increase of creatinine, urea and potassium serum levels was established. No significant difference in the therapeutic effect of compared drugs was revealed.


1. Bershova T. V., Bakanov M. I., Serbin V. I. Meditsinsky nauchny i metodichesky zhurnal. 2003;13: 83–92.
2. Korzun A. I., Kirillova M. V. Ekologiya cheloveka. 2003;2:16–22.
3. Mutafyan O. A. Detskaya kardiologiya. 2009;503
4. Skvortsov V. V., Tumarenko A. V., Fomina N. G., Zotova A. A. Russky meditsinsky zhurnal. 2010;26:1588–1593.
5. Chazova I. Ye. Consilium medicum. 2008;11(10):11–14.
6. Andrews R. E., Fenton M. J., Ridount D. A. Circulation. 2008;117(1):79–84.

Keywords: dilated cardiomyopathy, angiotensin converting enzyme, angiotensin converting enzyme inhibitors, children

Stavropol State Medical Academy
Pyatigorsk State Research Institute of Balneotherapeutics
Pyatigorsk State Pharmaceutical Academy